Bosun Asset Management’s Bristol-Myers Squibb BMY Stock Holding History

Bosun Asset Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-13,716	Closed	-$744K	–	162
2024 Q1	$744K	Sell	13,716 -1,193	-8%	-$60.8K	0.42%	68
2023 Q4	$765K	Buy	14,909 +1,805	+14%	+$94.7K	0.76%	31
2023 Q3	$761K	Sell	13,104 -596	-4%	-$36.5K	0.82%	27
2023 Q2	$876K	Buy	13,700 +1,200	+10%	+$80.5K	0.86%	24
2023 Q1	$866K	Buy	12,500 +7,900	+172%	+$557K	0.99%	22
2022 Q4	$331K	Sell	4,600 -100	-2%	-$7.54K	0.47%	42
2022 Q3	$334K	Buy	+4,700	New	+$341K	0.52%	37

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bosun Asset Management's BMY Position: Q2 2024 in Review

Bosun Asset Management sold out of Bristol-Myers Squibb (BMY) in Q2 2024, closing a stake of 13,716 shares — an estimated $744K sold.

Bosun Asset Management first reported a position in BMY in Q3 2022 and held it in 7 quarters. The position peaked at $876K in Q2 2023. 2,148 funds tracked by Wall St. Rank hold BMY as of Q2 2024.

Bosun Asset Management reported no remaining Bristol-Myers Squibb position as of Q2 2024 after selling out during the quarter.
Bosun Asset Management sold 13,716 Bristol-Myers Squibb shares in Q2 2024, an estimated $744K.
Bosun Asset Management first reported a position in Bristol-Myers Squibb in Q3 2022 and held it in 7 quarters.
Bosun Asset Management's Bristol-Myers Squibb position peaked at $876K in Q2 2023.
2,148 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2024.

Based on Bosun Asset Management's 13F filing for Q2 2024, filed 14 Aug 2024.